The here-presented protective effects of CD40-TRAF6 inhibition align with our previous findings in db/db mice, where the same compound improved endothelial dysfunction, reduced ROS formation, and decreased cardiac expression of inflammatory markers [4]. This evidence concerns the gene CD40 and endothelial dysfunction.